Recall Information
Recall#

FDA:      Feb 1 2019
Health Canada: RA-69020

Stryker announced today that the company is launching a voluntary field action on specific units of the LIFEPAK 15 Monitor/Defibrillators.

Hazard: The company is notifying certain LIFEPAK 15 customers of an issue that may cause the device to lock up after a defibrillation shock is delivered. The lock-up condition is defined as a blank monitor display with LED lights on, indicating power to the device, but no response in the keypad and device functions. A device in this condition has the potential to delay delivery of therapy, and this delay in therapy has the potential to result in serious injury or death.

Remedy: The company is contacting customers with impacted devices to schedule the correction of their device(s), which will include an update to the firmware for a component on the System Printed Circuit Board Assembly.  Stryker anticipates that all devices subject to this field action will be serviced by December 31, 2019.  If a customer experiences this issue, they should contact Stryker as soon as possible at 1 800 442 1142 and selecting option 7.

Since the initial commercialization of LIFEPAK 15 in 2009, Stryker has become aware of 58 complaints reported globally for this issue, including 6 events in which the patient died following a delay in therapy. In all six of these cases, at least one shock was delivered prior to the device experiencing the lock-up condition. There are 13,003 devices potentially impacted by this issue and within scope of this field action.

The company is instructing customers to continue to use their LIFEPAK 15 Monitor/Defibrillator according to the Operating Instructions until the correction can be completed.  Device Automatic Self-Tests do not identify this fault, as it occurs during defibrillation.  Customers should continue to perform the daily check as described in the Operator’s Checklist, specifically, the QUIK-COMBO therapy cable check as described in the General Maintenance and Testing Section (pages 10-4 and the LIFEPAK 15 Monitor/Defibrillator Operator’s Checklist, number 7).

For more information, please visit:
FDA –     https://www.fda.gov/Safety/Recalls/ucm630455.htm

Health Canada – http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69020r-eng.php